Overview

Effect of Early High-dose Epoetin Alfa During Cardiac Arrest (Pilot Study)

Status:
Completed
Trial end date:
2004-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the possible neuroprotective effect of early high dose erythropoietin alpha after out of hospital cardiac arrest (OHCA).
Phase:
Phase 3
Details
Lead Sponsor:
Janssen Cilag S.A.S.